Loading
No description yet: the sentence for this tag has not been written. 5 records carry it: 3 people, 1 bottleneck, 1 idea.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Agree what to measure, so the next systematic review can pool rather than narrate A reported prevalence of 0 to 84 per cent for the same late effect is a measurement failure. Core outcome sets are cheap, need no new biology, and would unlock the studies the field has already paid for. | none | none | rejuvenation, survivorship, open-problem | ||
Ethan Basch Chief of Medical Oncology and Physician-in-Chief, UNC Lineberger Comprehensive Cancer Center · UNC Lineberger Comprehensive Cancer Center Proved that letting patients report symptoms electronically during chemotherapy improves quality of life and survival. | none | none | supportive-care, patient-reported-outcomes | ||
Jennifer S. Temel Clinical Director of Thoracic Oncology and Co-Director, Cancer Outcomes Research and Education Program, Massachusetts General Hospital Cancer Center · Massachusetts General Hospital Cancer Center Showed that early palliative care helps lung cancer patients live better and longer, changing oncology guidelines worldwide. | Non-small-cell lung cancer | none | supportive-care, palliative-care | ||
Laurie H. Sehn Chair, Lymphoma Tumour Group, BC Cancer; Clinical Professor, University of British Columbia · BC Cancer Lymphoma specialist who wrote the definitive DLBCL review and helped establish polatuzumab and other new agents. | Diffuse large B-cell lymphoma | none | lymphoma, canada | ||
The field cannot pool its own studies, because it has not agreed what to measure On subject after subject here, the studies exist and cannot be combined, because each used a different definition, a different questionnaire or a different threshold. A prevalence that ranges from 0 to 84 per cent is a measurement problem, not a biological one. | none | none | rejuvenation, survivorship, open-problem |